# Evident Unveils Pramana POD Benchtop Scanner for Small and Medium-Sized Pathology Labs

> Evident launched the Pramana POD benchtop whole slide imaging scanner at Pathology Visions 2026, delivering true 40X imaging at 25 slides per hour.

- Published: 2026-10-17T01:04:49+00:00
- Section: Product Launches
- Author: News Desk
- URL: https://newsforagent.com/news/2026-10-17/evident-pramana-pod-scanner-launch
- Source: [PR Newswire](https://www.prnewswire.com/news-releases/evident-expands-its-pramana-digital-pathology-portfolio-to-support-small-and-medium-sized-labs-302911716.html)

## Key takeaways

- Evident announced the Pramana POD benchtop whole slide imaging scanner at Pathology Visions 2026.
- The scanner delivers true 40X imaging at 25 slides per hour under defined conditions.
- Prasanth Perugupalli, Vice President of Digital Pathology at Evident, said Pramana technology can help labs of varying sizes reduce the need for post-scan QA.

[Evident](https://akta.pro/company-profiles/00058hk/evident-corporation) announced the Pramana POD benchtop whole slide imaging scanner at Pathology Visions 2026 on October 17, 2026, a system built for small and medium-sized laboratories and specialty applications within larger institutions. The company said the scanner delivers true 40X imaging at 25 slides per hour under defined conditions. [PR Newswire](https://www.prnewswire.com/news-releases/evident-expands-its-pramana-digital-pathology-portfolio-to-support-small-and-medium-sized-labs-302911716.html) carried the announcement.

## How the Pramana POD Scanner Works

The Pramana POD scanner automates imaging with an advanced tissue finder, extensive label detection, and automated focal plane and scan-profile selection. Built-in image-quality assessment helps deliver pathologist-ready whole slide images and identify scans that may require further review. Volumetric imaging captures multiple focal planes to support the selection of sharp focal information across the scanned area.

Evident designed the benchtop system to extend its Pramana autonomous whole slide imaging technology to smaller laboratories. The Pramana series of autonomous WSI scanners is suited for most brightfield imaging applications, including histopathology, core biopsies, hematology, cytology, and microbiology.

"Pramana WSI technology has received tremendous acceptance from pathology labs across academic medical centers and network labs across the United States," said Prasanth Perugupalli, Vice President of Digital Pathology, Evident. "By incorporating quality assurance into the whole slide imaging process, Pramana technology can help labs of varying sizes reduce the need for post-scan QA and the associated costs and delays."

"Scientific advances move quickly, but laboratory infrastructure changes slowly," Perugupalli added. "With the Pramana POD scanner, small and medium-sized labs can build as their needs evolve."

## Pramana's Place in Evident's Portfolio

Evident acquired Pramana, a digital pathology AI company, in August 2025 to add fully autonomous image scanning and AI-driven diagnostic workflows to its clinical portfolio, according to akta.pro [company records](https://akta.pro/company-data). The same records list a partnership with Siemens Healthineers to advance digital pathology at Klinikum Ludwigshafen hospital. Evident was established in April 2023 as a standalone company comprising the former Scientific Solutions business of Olympus, and its APAC headquarters is in Singapore.

## CrestOptics Deal and Image Awards

Evident finalized its acquisition of CrestOptics S.p.A., a Rome-based company specializing in optical imaging systems for confocal and super-resolution microscopy, in October 2026, PR Newswire reported. In April 2026, Evident announced the winners of its sixth annual Image of the Year Award, selecting entries from submissions across 34 countries, News-Medical reported.

## Where to Find the Pramana POD

Evident lists the Pramana POD benchtop WSI scanner at evidentscientific.com/products/slide-scanners/pramana-pod. The company states the product is for research use only and not for use in diagnostic procedures, with future clinical availability subject to applicable regulatory authorization.

## Companies in this story

- [Evident Corporation company profile](https://akta.pro/company-profiles/00058hk/evident-corporation) · website: https://www.evidentscientific.com

---
News for Agent · https://newsforagent.com/llms.txt